Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.
about
Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modellingCapability of utilizing CYP3A5 polymorphisms to predict therapeutic dosage of tacrolimus at early stage post-renal transplantation.Dosing equation for tacrolimus using genetic variants and clinical factorsLimited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique.Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study.Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipientsInclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation.Importance of hematocrit for a tacrolimus target concentration strategy.Once- versus twice-daily tacrolimus: are the formulations truly equivalent?Immunosuppression and allograft rejection following lung transplantation: evidence to date.Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts.Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?Tacrolimus population pharmacokinetics according to CYP3A5 genotype and clinical factors in Chinese adult kidney transplant recipients.A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach.Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation.Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients.Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone.Population PKPD of voclosporin in renal allograft patients.
P2860
Q31097010-4F5EC8AF-F3E4-43BA-8EF1-1394444FD397Q34571036-697E7611-8D8E-4A3C-80CB-F103E3B604FEQ35016679-729DBC05-928C-4EE8-B322-ABAD82B2910EQ35629782-003DF917-94EB-4058-B369-D5C3342EAC42Q35729869-9D4E2D50-701A-4D19-B60C-F7550F4B814BQ36113092-D51D4D0F-A408-4213-B59A-1617654FDB36Q36465101-4446C11F-CCF5-47DB-943E-02B36F249C6BQ36806621-F9402342-D060-4F4B-A1FE-C23B57B79EDBQ37126092-F2FB999E-2367-4261-849E-F6A05A5717D9Q37366663-3D5D1547-6B7C-49F0-8A7B-7FAB6B7BA26EQ37469289-CA6C8453-A108-4B4F-B9B0-B92A9CA0B3B6Q37921280-1AC03D57-D52E-4CD9-9461-A451057B29EDQ38154197-4113D3DA-C2BD-4734-955E-5577110DFCCEQ38514054-3560D280-F375-4E5A-AB77-AE1A3581A1D0Q38587538-4A13E972-EC47-400C-8665-EA92BF6B52F3Q38612229-6C242928-923C-49E1-8192-39FD93CF21F4Q38809767-661F380B-202C-432A-8B44-4B297916B78CQ38840993-9BA5B480-8D7D-438C-AAB9-530D3FF445F1Q39041618-3FA6BD7F-28CF-4230-9AA0-7332BA5CC959Q42215557-5C0A2E8A-86B9-4997-B5EB-16A3628FA33EQ43570020-FC0C5034-2D10-4AC3-A891-8CEF7BABB824Q45794517-5D8EB120-829E-41BD-BAEA-652F097B29AFQ51140785-5DDA34FD-2070-4D4E-A69C-931E11E8F02B
P2860
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@ast
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@en
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@nl
type
label
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@ast
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@en
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@nl
prefLabel
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@ast
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@en
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@nl
P2093
P2860
P50
P1476
Population pharmacokinetic mod ...... ograf and once daily Advagraf.
@en
P2093
Annick Rousseau
Brenda C M de Winter
Jean-Baptiste Woillard
P2860
P304
P356
10.1111/J.1365-2125.2010.03837.X
P407
P577
2011-03-01T00:00:00Z